Search Orphan Drug Designations and Approvals
-
Generic Name: | Benzophenone-3, octylmethoxycinnamate, avobenzone, titanium dioxide, zinc oxide |
---|---|
Date Designated: | 08/13/2001 |
Orphan Designation: | For the prevention of visible light induced skin photosensitivity as a result of porfimer sodium photodynamic therapy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Fallien Cosmeceuticals Ltd. 677 W. Dekalb Pike King of Prussia, Pennsylvania 19406 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-